Peter Sands

Peter Sands

executive Unknown

Peter Sands is the executive director of the Global Fund for HIV, TB and Malaria, where he advocates for innovative solutions to combat global health issues. A former investment banker, Sands emphasizes the importance of economic arguments in securing funding for health initiatives, particularly in the fight against HIV. He has been instrumental in promoting the roll-out of lenacapavir, a groundbreaking anti-HIV jab, demonstrating his commitment to improving health outcomes in low-income countries.

Global Media Ratings
Dominance
0.01%
Persistence
0 wks
Reach
197,002
Power
8,999$
Sentiment
8.00
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
Guyana 1 8.00 0.08% +0% 786,552 619 $6,000 5$
Germany 1 8.00 0.06% +0% 83,783,942 51,750 $3,845,000 2,375$
United States 1 8.00 0.03% +0% 331,002,651 102,924 $21,000,000 6,530$
Ghana 1 8.00 0.13% +0% 31,072,945 41,709 $67,000 90$
Totals 4 446,646,090 197,002 $24,918,000 9,000$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Ghana Ghana: Peter Sands, executive director of the Global Fund, stated that lenacapavir can fundamentally change the trajectory of the HIV epidemic. 8

Daily Graphic – state-owned Ghanaian newspaper, est. 1950: WHO recommends twice-a-year HIV prevention shot

United States United States: Peter Sands, executive director of the Global Fund, stated that lenacapavir can fundamentally change the trajectory of the HIV epidemic. 8

CNN: WHO recommends twice-a-year HIV prevention shot as concern looms over funding for global HIV fight

Guyana Guyana: Peter Sands, executive director of the Global Fund, discussed the availability of a new tool to prevent HIV infection. 8

Stabroek News: Gilead, Global Fund finalize plan to supply HIV prevention drug to poor countries

United Kingdom United Kingdom: Peter Sands, the executive director of the Global Fund, stated that they are not backing off the ambition to deliver Lenacapivir to two million people if they can. 6

The Guardian: Elon Musk says Doge didn’t cut HIV programs. But it threw a ‘miracle drug’ into chaos | USAID